Fundz Deep Dive
Everything you need to win Micron Biomedical — in one platform.
Who to reach, what to say, and why now on Micron Biomedical — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Micron Biomedical — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Micron Biomedical Secures $43 Million Grant to Improve Measles and Rubella Vaccine Coverage
Jan 07, 2025•over 1 year ago
Contract Type
partnership
AtlantaBiotechnologyHealth CareDescription
Micron Biomedical has secured a $7.5 million grant from the Bill & Melinda Gates Foundation, bringing the total grant funding to $43 million. The grant will support efforts to increase access to the measles-rubella (MR) vaccine and fund ongoing manufacturing scale-up efforts and activities to support a phase 2 trial in infants.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months